Top Markets
Coin of the day
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Rangering i aksjer #13779
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Aksjekurs
$12.63
Markedsverdi
$458.19M
Endring (1 dag)
-3.26%
Endring (1 år)
-
Land
US
Handel Evommune, Inc. (EVMN)

Kategori

Historikk for aksjesplitt for Evommune, Inc. (EVMN)
Aksjen Evommune, Inc. (symbol: EVMN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 31, 2026.
Én EVMN-aksje kjøpt før Aug 31, 2026 tilsvarer i dag 0 EVMN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH